A possible explanation could be that lnc‐PCAT1 promotes malignant cell growth via different pathways, including NF‐κB pathway, MAPK‐, and Wnt/β‐catenin signaling pathways, which influences the development and pathogenesis of MM.11, 12, 20, 21. This evidence concerns the gene PCAT1 and Miyoshi myopathy.